Sun Pharma’s St. Peter Outlines Company’s Ambitious Plan to Build Ophthalmology Pipeline
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 143″]
Jerry St. Peter, VP & head, ophthalmic business, says the ophthalmology newcomer is making great progress in building a broad pipeline to treat eye disease including dry eye and ocular pain. In this interview he reviews several acquisitions and partnerships the company has made over the past 24 months.
Jerry St. Peter
Jerry St. Peter is Vice President and Head for Sun Ophthalmics, a newly formed Division of Sun Pharmaceutical Industries, Inc. In this role, Mr. St. Peter is responsible for creating the U.S strategy and building a new Ophthalmic Business Unit, focused on specialty pharmaceuticals.